| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8649494 | Cardiovascular Revascularization Medicine | 2017 | 6 Pages |
Abstract
The routine use of DAPT and WF for prophylaxis against LVT formation following an anterior STEMI with associated decrease in LVEF and wall motion abnormalities, appears to result in no mortality benefit or reduction in stroke rates, but may increase the frequency of major bleeding.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Molecular Medicine
Authors
Nathaniel Moulson, Stephen A. LaHaye, Olivier F. Bertrand, Jimmy MacHaalany,